CAR T-cell therapies
- Business Wire
Invivoscribe Launches Grant Program to Support Novel Applications for Sequence-Based Analyses of the Immune System
SAN DIEGO–(BUSINESS WIRE)–#invivoscribe–Invivoscribe, a global leader in precision diagnostics, has announced the launch of an Immune Biomarker Discovery grant program,…
Read More »